1.Construction of evaluation index system for difficulty of nursing work items in post anesthesia care unit
Peiyu LIU ; Nuocui ZHANG ; Zhuanyun ZHANG ; Xueyun LI ; Zhengliang MA ; Xiaoping GU
Chinese Journal of Practical Nursing 2023;39(34):2641-2648
Objective:To explore the nursing work items and the technical difficulty in post anesthesia care unit, so as to provide the basis for accurate calculation of anesthesia nursing workload and reasonable matching of human resources.Methods:The primary and secondary indicators of the nursing working system in post anesthesia care unit were determined through the literature review and group discussion. Delphi method was used to revise the indicators and evaluate the importance and difficulty degree of the indicators. Finally, analytic hierarchy process and linear weighted sum method were used to calculate the weight value and difficulty coefficient of each index.Results:The positive coefficients of the experts in the two rounds were 100.00%, the authority coefficients of the experts were 0.90 and 0.96, the variation coefficients ranged from 0.000 to 0.342 and 0.042 to 0.307, and the Kendall coefficients were 0.239 and 0.273 (both P<0.01). The evaluation index system of the difficulty of nursing work in post anesthesia care unit was finally composed of 10 primary indicators and 85 secondary indicators. The weight of the primary index ranged from 0.016 4 to 0.186 4, and the weight of the secondary index ranged from 0.000 8 to 0.064 3. The standardized difficulty coefficient of the secondary index ranged from 1.02 to 1.59. Conclusions:The evaluation index system of the difficulty of nursing work items in post anesthesia care unit was comprehensive and the difficulty coefficient was in line with the actual clinical work in this study, which provides reference for the follow-up scientific calculation of nursing workload and human resources matching in post anesthesia care unit.
2.Application of online PBL teaching in clinical teaching of anesthesia nursing
Chinese Journal of Medical Education Research 2020;19(6):715-719
Objective:To explore the effect of online PBL teaching in clinical practice of anesthesia nursing during the coronavirus disease 2019 (COVID-19) epidemic.Methods:From January 2020 may 2020, 84 clinical nursing students who received anesthesia nursing teaching in our hospital were selected and randomized into the control group ( n=42) and the experimental group ( n=42). According to the different teaching methods, the control group adopted routine online teaching mode and the experimental group adopted online PBL teaching mode. SPSS 21.0 was used to compare scores of the theoretical knowledge, nursing evaluation, nursing plan, clinical operation and total scores of the two groups. Results:There was no significant difference in theoretical knowledge between the two groups ( P>0.05). The nursing evaluation, nursing plan, clinical operation and total scores of the anesthesia nursing students in the experimental group were significantly higher than those in the control group( P<0.05), and the experimental group had a significantly higher degree of teaching satisfaction than the control group ( P<0.05). Conclusion:During the special period of the COVID-19 epidemic, the online PBL teaching has achieved good teaching effect of online practice of anesthesia nursing specialty, which has ensured "classes suspended but learning continues", and improved the comprehensive examination results of the students. This teaching mode has gained good teaching satisfaction, worthy of clinical promotion and further study.
3.Obstertric nurse's ability to treat maternal pain in cesarean section and its influencing factors
Ying DU ; Guangmei SHAO ; Wei HUA ; Lin RUI ; Zhuanyun ZHANG
Chinese Journal of Modern Nursing 2019;25(31):4015-4018
Objective To investigate the pain management ability of obstetric nurses in puerperants undergoing cesarean section, and to provide some reference for improving the professional knowledge and service ability of obstetric nursing staff. Methods From November 2017 to November 2018, 162 staff in charge of nursing puerperants undergoing cesarean section in Obstetrics Department of 3 ClassⅢ Grade A hospitals were selected by convenience sampling method. General Information Questionnaire, Nurses' Knowledge and Attitudes Survey Regarding Pain(NKAS) were used to investigate and study and compare the pain management ability of nurses with different data. A total of 162 questionnaires were sent out and 156 valid questionnaires were recovered with a recovery rate of 96.30%. Results The scores of NKAS scale of 156 nurses were (15.16±5.42). The scores of "general knowledge of pain", "knowledge of analgesics","knowledge of pain assessment" and "knowledge of pain intervention" were (3.47±0.95), (6.89±1.24), (3.07±0.73) and (1.65±0.98), respectively. There was significant difference in NKAS scores between nurses with different ages, nurses' professional level, education and working years, and the difference was statistically significant (P<0.05). Multiple linear regression analysis showed that nurses' education and working years were the influencing factors of their pain management ability (P<0.05). Conclusions The pain management ability of obstetric caesarean section nurses in Nanjing Class Ⅲ Grade A Hospital is low. It is suggested to strengthen the training of pain management ability of obstetric caesarean section nurses with short working length and low professional levels in order to provide better nursing service for puerperants.
4.Summary of the best evidence for perioperative assessment and intervention in patients with chronic obstructive pulmonary disease
Qing WANG ; Zhuanyun ZHANG ; Ruocui ZHANG ; Shanshan ZHUANG ; Yutong YE ; Yu'e SUN
Journal of Clinical Medicine in Practice 2023;27(24):53-58
Objective To analyze and integrate the best evidence of perioperative assessment and management in patients with chronic obstructive pulmonary disease(COPD).Methods Guideline websites,Chinese and English databases,related society websites were searched systematically to search and extract for guidelines,clinical decisions,recommended practice,evidence summaries,sys-tematic reviews and expert consensus on perioperative assessment and intervention in patients with COPD.The retrieval time was from the establishment of the database to January 31,2023.Results A total of 14 literatures were included:5 guidelines,3 expert consensus,3 clinical decisions,and 3 systematic reviews.Twenty-six pieces of evidence were collected from seven aspects,including gener-al principles,risk factors,nursing assessment,pulmonary rehabilitation nursing,airway manage-ment,effectiveness evaluation and shift management.Conclusion This study summarizes the best evidence of perioperative evaluation and intervention in patients with COPD,which can provide evi-dence-based evidence for perioperative management in patients with COPD.
5.Summary of the best evidence for perioperative assessment and intervention in patients with chronic obstructive pulmonary disease
Qing WANG ; Zhuanyun ZHANG ; Ruocui ZHANG ; Shanshan ZHUANG ; Yutong YE ; Yu'e SUN
Journal of Clinical Medicine in Practice 2023;27(24):53-58
Objective To analyze and integrate the best evidence of perioperative assessment and management in patients with chronic obstructive pulmonary disease(COPD).Methods Guideline websites,Chinese and English databases,related society websites were searched systematically to search and extract for guidelines,clinical decisions,recommended practice,evidence summaries,sys-tematic reviews and expert consensus on perioperative assessment and intervention in patients with COPD.The retrieval time was from the establishment of the database to January 31,2023.Results A total of 14 literatures were included:5 guidelines,3 expert consensus,3 clinical decisions,and 3 systematic reviews.Twenty-six pieces of evidence were collected from seven aspects,including gener-al principles,risk factors,nursing assessment,pulmonary rehabilitation nursing,airway manage-ment,effectiveness evaluation and shift management.Conclusion This study summarizes the best evidence of perioperative evaluation and intervention in patients with COPD,which can provide evi-dence-based evidence for perioperative management in patients with COPD.
6.Current situation and influencing factors of clinical nurses' anxiety about obtaining information
Zhuanyun ZHANG ; Ruocui ZHANG ; Wei HUA ; Zhengliang MA ; Xiaoping GU
Chinese Journal of Modern Nursing 2021;27(10):1363-1366
Objective:To investigate the current situation of clinical nurses' anxiety about obtaining information and analyze the influencing factors of information anxiety degree.Methods:The convenient sampling method was used to conduct a cross-sectional survey, and 339 clinical nurses from 4 general hospitals in Nanjing from April to June 2020 were selected as the research objects. The general information questionnaires and Information Anxiety Scale were used for the investigation. In this study, a total of 339 questionnaires were issued and 324 valid questionnaires were returned, with an effective recovery rate of 95.58%.Results:The total score of Information Anxiety Scale of 324 clinical nurses was (100.96±19.83) and the average score of items was (2.69±0.25) . The average scores of each dimension item from high to low were information demand, information utilization ability, retrieval system quality, information retrieval ability, cognitive type and knowledge structure. The results of multiple linear regression analysis showed that age, professional title, education level and hospital grade were the main factors affecting the degree of information anxiety of clinical nurses ( P<0.05) . Conclusions:Age, professional title, education level and hospital grade are the main influencing factors of information anxiety degree of clinical nurses. Nursing managers should cultivate the awareness of information acquisition of clinical nurses and enhance their ability to acquire information independently, so as to reduce their anxiety about acquiring information.
7.Mebendazole effectively overcomes imatinib resistance by dualtargeting BCR/ABL oncoprotein and ββ-tubulin in chronic myeloid leukemia cells
Li YANG ; Zhuanyun DU ; Yuhang PENG ; Wenyao ZHANG ; Wenli FENG ; Ying YUAN
The Korean Journal of Physiology and Pharmacology 2025;29(1):67-81
To target the pivotal BCR/ABL oncoprotein in chronic myeloid leukemia (CML) cells, tyrosine kinase inhibitors (TKIs) are utilized as landmark achievements in CML therapy. However, TKI resistance and intolerance remain principal obstacles in the treatment of CML patients. In recent years, drug repositioning provided alternative and promising perspectives apart from the classical cancer therapies, and promoted anthelmintic mebendazole (MBZ) as an effective anti-cancer drug in various cancers. Here, we investigated the role of MBZ in CML treatment including imatinib-resistant CML cells. Our results proved that MBZ inhibited the proliferation and induced apoptosis in CML cells. We found that MBZ effectively suppressed BCR/ABL kinase activity and MEK/ERK signaling pathway by reducing p-BCR/ABL and p-ERK levels with ABL1 targeting ability. Meanwhile, MBZ directly targeted the colchicine-binding site of β-tubulin protein, hampered microtubule polymerization and induced mitosis arrest and mitotic catastrophe. In addition, MBZ increased DNA damage levels and hampered the accumulation of ataxia-telangiectasia mutated and DNA-dependent protein kinase into the nucleus. This work discovered that anthelmintic MBZ exerts remarkable anticancer effects in both imatinib-sensitive and imatinib-resistant CML cells in vitro and revealed mechanisms underlying. From the perspective of drug repositioning and multi‐target therapeutic strategy, this study provides a promising option for CML treatment, especially in TKI-resistant or intolerant individuals.
8.Mebendazole effectively overcomes imatinib resistance by dualtargeting BCR/ABL oncoprotein and ββ-tubulin in chronic myeloid leukemia cells
Li YANG ; Zhuanyun DU ; Yuhang PENG ; Wenyao ZHANG ; Wenli FENG ; Ying YUAN
The Korean Journal of Physiology and Pharmacology 2025;29(1):67-81
To target the pivotal BCR/ABL oncoprotein in chronic myeloid leukemia (CML) cells, tyrosine kinase inhibitors (TKIs) are utilized as landmark achievements in CML therapy. However, TKI resistance and intolerance remain principal obstacles in the treatment of CML patients. In recent years, drug repositioning provided alternative and promising perspectives apart from the classical cancer therapies, and promoted anthelmintic mebendazole (MBZ) as an effective anti-cancer drug in various cancers. Here, we investigated the role of MBZ in CML treatment including imatinib-resistant CML cells. Our results proved that MBZ inhibited the proliferation and induced apoptosis in CML cells. We found that MBZ effectively suppressed BCR/ABL kinase activity and MEK/ERK signaling pathway by reducing p-BCR/ABL and p-ERK levels with ABL1 targeting ability. Meanwhile, MBZ directly targeted the colchicine-binding site of β-tubulin protein, hampered microtubule polymerization and induced mitosis arrest and mitotic catastrophe. In addition, MBZ increased DNA damage levels and hampered the accumulation of ataxia-telangiectasia mutated and DNA-dependent protein kinase into the nucleus. This work discovered that anthelmintic MBZ exerts remarkable anticancer effects in both imatinib-sensitive and imatinib-resistant CML cells in vitro and revealed mechanisms underlying. From the perspective of drug repositioning and multi‐target therapeutic strategy, this study provides a promising option for CML treatment, especially in TKI-resistant or intolerant individuals.
9.Mebendazole effectively overcomes imatinib resistance by dualtargeting BCR/ABL oncoprotein and ββ-tubulin in chronic myeloid leukemia cells
Li YANG ; Zhuanyun DU ; Yuhang PENG ; Wenyao ZHANG ; Wenli FENG ; Ying YUAN
The Korean Journal of Physiology and Pharmacology 2025;29(1):67-81
To target the pivotal BCR/ABL oncoprotein in chronic myeloid leukemia (CML) cells, tyrosine kinase inhibitors (TKIs) are utilized as landmark achievements in CML therapy. However, TKI resistance and intolerance remain principal obstacles in the treatment of CML patients. In recent years, drug repositioning provided alternative and promising perspectives apart from the classical cancer therapies, and promoted anthelmintic mebendazole (MBZ) as an effective anti-cancer drug in various cancers. Here, we investigated the role of MBZ in CML treatment including imatinib-resistant CML cells. Our results proved that MBZ inhibited the proliferation and induced apoptosis in CML cells. We found that MBZ effectively suppressed BCR/ABL kinase activity and MEK/ERK signaling pathway by reducing p-BCR/ABL and p-ERK levels with ABL1 targeting ability. Meanwhile, MBZ directly targeted the colchicine-binding site of β-tubulin protein, hampered microtubule polymerization and induced mitosis arrest and mitotic catastrophe. In addition, MBZ increased DNA damage levels and hampered the accumulation of ataxia-telangiectasia mutated and DNA-dependent protein kinase into the nucleus. This work discovered that anthelmintic MBZ exerts remarkable anticancer effects in both imatinib-sensitive and imatinib-resistant CML cells in vitro and revealed mechanisms underlying. From the perspective of drug repositioning and multi‐target therapeutic strategy, this study provides a promising option for CML treatment, especially in TKI-resistant or intolerant individuals.
10.Mebendazole effectively overcomes imatinib resistance by dualtargeting BCR/ABL oncoprotein and ββ-tubulin in chronic myeloid leukemia cells
Li YANG ; Zhuanyun DU ; Yuhang PENG ; Wenyao ZHANG ; Wenli FENG ; Ying YUAN
The Korean Journal of Physiology and Pharmacology 2025;29(1):67-81
To target the pivotal BCR/ABL oncoprotein in chronic myeloid leukemia (CML) cells, tyrosine kinase inhibitors (TKIs) are utilized as landmark achievements in CML therapy. However, TKI resistance and intolerance remain principal obstacles in the treatment of CML patients. In recent years, drug repositioning provided alternative and promising perspectives apart from the classical cancer therapies, and promoted anthelmintic mebendazole (MBZ) as an effective anti-cancer drug in various cancers. Here, we investigated the role of MBZ in CML treatment including imatinib-resistant CML cells. Our results proved that MBZ inhibited the proliferation and induced apoptosis in CML cells. We found that MBZ effectively suppressed BCR/ABL kinase activity and MEK/ERK signaling pathway by reducing p-BCR/ABL and p-ERK levels with ABL1 targeting ability. Meanwhile, MBZ directly targeted the colchicine-binding site of β-tubulin protein, hampered microtubule polymerization and induced mitosis arrest and mitotic catastrophe. In addition, MBZ increased DNA damage levels and hampered the accumulation of ataxia-telangiectasia mutated and DNA-dependent protein kinase into the nucleus. This work discovered that anthelmintic MBZ exerts remarkable anticancer effects in both imatinib-sensitive and imatinib-resistant CML cells in vitro and revealed mechanisms underlying. From the perspective of drug repositioning and multi‐target therapeutic strategy, this study provides a promising option for CML treatment, especially in TKI-resistant or intolerant individuals.